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Objectives: Endovascular treatment of traumatic aortic injury (TAI) is an alternative to open repair (OR) in patients with
blunt trauma. We report our initial experience after integration of endovascular repair using thoracic devices.
Methods: A retrospective review of a prospectively collected institutional trauma registry was performed. Between
September 2005 and November 2008, 71 patients with TAI presented to our institution. Based on imaging, TAIs were
classified into grade 1-4 in severity. These included: grade 1, intimal tear; grade 2, intramural hematoma; grade 3, aortic
pseudoaneurysm; and grade 4, free rupture. Initial management included resuscitation, blood pressure control, and
treatment of associated injuries. After stabilization, all patients were considered for thoracic endovascular aortic repair
(TEVAR) using a thoracic device. If contraindicated, candidates underwent OR. Outcome measures were mortality,
stroke, paraplegia, intensive care unit (ICU), and hospital stay.
Results: The mean age was 39.8 years, with 50 males. The mean injury severity score (ISS) was 42.6. Nineteen (27%)
patients with a mean ISS of 60 died shortly after arrival prior to any vascular intervention. Ten (14%) patients with grade
1 injuries were managed medically. The remaining 42 (59%) patients with grade 2 and 3 injuries underwent repair.
Median interval between admission and repair was 4.3 days (range, 0-109 days). Fifteen (21%) patients with a mean ISS
of 34.4 underwent OR with no mortality, stroke, or paraplegia. Twenty-seven (38%) patients with a mean ISS of 36.7
underwent TEVAR with no mortality or paraplegia. One TEVAR patient suffered a perioperative stroke. Twenty-two
patients had a TAG (W.L. Gore & Associates, Flagstaff, Ariz) device. Four patients had a Talent Thoracic (Medtronic
Vascular, Santa Rosa, Calif), and 1 patient had an Excluder (W.L. Gore) device. The left subclavian artery was covered in
13 (48%) patients. Patients who underwent TEVAR were older than those who had OR (47.8 vs 31.1 years, P < .006).
The aortic diameter proximal to the injury was larger in the TEVAR group (24.4 vs 19.6 mm, P < .0001). There was no
difference in the mean ICU or hospital length of stay between the two groups. Mortality correlated with the ISS score
(P < .0001). Median follow-up time was 19.4 months (range, 0-27). Only 56% of the TEVAR patients were fully
compliant with their surveillance imaging protocol.
Conclusion: In this initial experience, the results of TEVAR did not differ from OR. Long-term follow-up is required to
determine the effectiveness of this treatment strategy. Adherence to follow-up imaging protocols is challenging in this
patient population. Next generation devices will make TEVAR applicable to a wider range of patients. ( J Vasc Surg
2009;49:1403-8.)Traumatic aortic injury (TAI) is the second most com-
mon cause of death after blunt trauma.1 The majority of
injuries result from automobile crashes. The mechanism is
thought to be related to differential forces that are created
between tissues secondary to deceleration. In the aorta, the
greatest strain occurs at the isthmus where a fixed aortic
arch connects to a relatively mobile descending thoracic
aorta.2 A 1958 article by Parmley et al3 reported an 85%
pre-hospital mortality in patients with TAI. Traditional
open repair (OR) has been associated with high morbidity
and mortality. A 20-year meta-analysis published in 1994
reported a mortality and paraplegia rate of 32% and 9.9%,
respectively.4
Thoracic endovascular aortic repair (TEVAR) offers
several advantages compared to OR for management of
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placing them at higher risk for a procedure that requires
open thoracotomy, single-lung ventilation, heparinization,
aortic clamping, and often multiple transfusions. Although
to date, no specific endograft has been approved by the
Food and Drug Administration (FDA) for treatment of
TAI, off-label use of commercially available devices is com-
mon. Several meta-analyses have documented significantly
improved outcomes with TEVAR compared to OR.5-7 We
report our initial experience with integration of TEVAR for
management of TAI at a major urban trauma center.
METHODS
A retrospective review of a prospectively collected insti-
tutional trauma registry was performed. This study was
approved by the Committee for the Protection of Human
Subjects (CPHS), which acts as the institutional review
board. Between September 2005 and November 2008, 71
patients with a diagnosis of TAI presented to our institu-
tion. Using imaging, we classified TAIs into four categories
based on severity (Fig 1). These included: grade 1, intimal
tear; grade 2, intramural hematoma; grade 3, aortic pseu-
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included resuscitation, blood pressure control, and treat-
ment of associated injuries. Patients with grade 1 injuries
underwent intravascular ultrasound (IVUS) and were man-
aged medically. After stabilization, the remaining patients
were considered for endovascular repair using a thoracic
device. The suitability of a patient for endovascular repair
was based on aortic diameter according to the manufactur-
er’s sizing recommendations for thoracic devices as well as
the location of the injury. Patients who were not endovas-
cular candidates underwent OR. Use of abdominal compo-
nent devices was considered in extreme circumstances
when neither a thoracic device nor OR was a suitable
option. Main outcome measures were mortality, stroke,
paraplegia, intensive care unit (ICU), and hospital stay.
Descriptive statistics were computed for all of the groups.
Hypothesis tests between the open and endovascular
groups were computed by contingency table methods for
categorical variables and by unpaired t tests or Wilcoxon
rank-sum tests as appropriate for the distributional charac-
teristics of the continuous variables. All computations were
performed using SAS software version 9.1.3 (SAS Institute,
Inc, Cary, NC). The null hypothesis was rejected at a
nominal P  .05.
Thoracic endovascular aortic repair. All endovascu-
lar procedures were performed under general anesthesia in
a hybrid operating room equipped with fixed imaging
equipment (Axiom, Siemens Medical, Malvern, Pa). In the
Fig 1. Classification systfirst two cases, a cerebrospinal fluid drainage catheter wasinserted based on our institutional protocol for patients
undergoing thoracic aneurysm repair. Due to the low risk
of paraplegia and our increasing comfort with the proce-
dure, this practice was later abandoned in patients with
TAI.
Intraoperatively, the abdomen and bilateral groins
were prepped in standard fashion. An arch aortogram was
performed through percutaneous femoral access. The loca-
tion of the injury was confirmed. The cerebrovascular anat-
omy was evaluated based on the arch angiogram, especially
if left subclavian artery coverage was planned. IVUS was
used selectively based on the discretion of the attending
surgeon. We have found IVUS especially useful in visualiz-
ing grade 2 aortic injuries which may be difficult to see on
angiogram. Open exposure of the contralateral femoral
artery was obtained through a transverse inguinal incision.
According to preoperative computed tomography (CT)
imaging scans, we generally selected the more suitable
(based on diameter, tortuosity, and calcification) iliac artery
for device placement. The patient was anticoagulated with
weight-based heparin protocol.
The thoracic device(s) (off-label) were selected based
on CT image scans according to manufacturer’s sizing
recommendations. Measurements were made based on
two-dimensional thin-cut axial CT scans with intravenous
(IV) contrast. An abdominal component device was used in
the case of a pediatric patient who could not tolerate a
thoracic device or OR. The device(s) was/were delivered
r traumatic aortic injury.and deployed using standard technique without any phar-
ultra
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needed to obtain a proximal landing zone or gain better
apposition with the lesser curvature of the aortic arch. A
policy of selective delayed subclavian artery revasculariza-
tion was maintained. Postdeployment balloon angioplasty
was performed selectively when incomplete apposition of
the graft at the proximal landing zone was noted. The
delivery devices were removed. The femoral arteriotomy
was repaired using polypropylene suture. The heparin was
reversed using protamine. The puncture site was managed
using a closure device or manual pressure. Postoperatively,
patients returned to the trauma surgical ICU. They were
subsequently discharged after treatment of other associated
injuries.
Open repair. All ORs were performed under general
anesthesia using a double lumen endotracheal tube. Neu-
romonitoring included somatosensory and motor-evoked
potential monitoring. Distal aortic perfusion using a Bio-
Medicus (Minneapolis, Minn) pump with an inline heat
exchanger was used with outflow cannulation from the left
inferior pulmonary vein to the distal descending thoracic
aorta or left common femoral artery. Systemic hepariniza-
tion was used at 1 mg/kg. Aortic clamping was performed
proximal to the left subclavian artery. The aorta was opened
longitudinally and the tear was inspected. Hemostasis was
obtained by over-sewing any bleeding intercostal arteries.
An appropriately sized woven Dacron tube graft was anas-
tomosed to the proximal aorta with a running 4-0 polypro-
pylene suture. The distal anastomosis was then performed
and the graft was flushed just prior to its completion.
Follow-up. The follow-up imaging protocol for the
TEVAR patients consisted of a CT scan at 1, 6, and 12
months, postoperatively, and yearly thereafter. The follow-up
imaging protocol for OR patients consisted of a yearly chest
x-ray. Follow-up information was gathered from office
charts and supplemented with telephone interviews when
necessary. For the purposes of this publication, these data
were also supplemented with the Social Security Death
Fig 2. Computed tomography (CT) and intravascularIndex.RESULTS
Among the cohort, themean age was 39.8 years (range,
14-87, 50 males). The mean injury severity score (ISS) was
42.6 (range, 16-75). The mechanisms of injury included
motor vehicle collision (n 51), motorcycle (n 7), auto
vs pedestrian (n  5), fall (n  5), and other (n  3).
Nineteen (27%) patients with a mean ISS of 60 died shortly
after arrival prior to any vascular intervention. Ten (14%)
patients with grade 1 injuries underwent IVUS and were
managed medically. There were no deaths in this group.
The remaining 42 (59%) patients with grade 2 and 3
injuries underwent repair. Representative CT scans and
IVUS images of patients with grade 1-3 injuries are dem-
onstrated in Figs 2-4. Median interval between admission
and repair was 4.3 days (range, 0-109 days). No patient
died from aortic rupture while awaiting repair. Fifteen
(21%) patients with a mean ISS of 34.4 underwent ORwith
no mortality, stroke, or paraplegia. Twenty-seven (38%)
patients with a mean ISS of 36.7 underwent TEVAR with
no morality or paraplegia. One (3.7%) TEVAR patient
suffered a perioperative stroke. A summary of the data is
listed in the Table. Twenty-two patients had a TAG device
(W.L. Gore & Associates, Flagstaff, Ariz). Four patients
had a Talent Thoracic device (Medtronic Vascular, Santa
Rosa, Calif), and 1 patient had an Excluder device (W.L.
Gore). The technical success rate was 100%. All but 3
patients required a single device. The left subclavian artery
was covered in 13 (48%) patients. No patients required an
iliac conduit. One patient with an associated brachial plexus
injury subsequently underwent a left carotid-subclavian
bypass. There were no other reinterventions. The patients
who underwent TEVAR were older than those who had
OR (47.8 vs 31.1 years, P  .006). The aortic diameter
proximal to the area of injury was significantly larger in the
TEVAR group (24.4 vs 19.6 mm, P .0001, range, 14-36
mm). There was no significant difference in the mean ICU
or hospital length of stay between the two groups. Mortal-
ity significantly correlated with the ISS score (P  .0001).
sound (IVUS) images of a grade I injury (intimal tear).Median follow-up time was 19.4 months (range, 0-27).
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their surveillance imaging protocol.
DISCUSSION
This study represents a modern series of patients with
TAI who presented to a large urban trauma center. First
and foremost, the findings confirm that despite modern
advances, TAI remains a very lethal condition for the esti-
mated 85% who die in the field and the 27% of the survivors
who expire within hours after arrival. A number of other
studies have documented the high early mortality of such
patients.8,9 Undoubtedly, the severity of the associated
injuries in this group (ISS 60) also plays a significant role.
In fact, the mean ISS was a significant predictor of mortal-
ity. The patients who survive the initial hospitalization,
therefore, represent a naturally selected cohort with more
stable aortic injuries. Our protocol consisted of initial sta-
bilization, blood pressure control, and treatment of associ-
ated injuries followed by delayed repair.9-11 Under this
protocol, no patient died secondary to aortic rupture while
awaiting repair.
The initiation of our series (August 2005) corresponds
Fig 3. Computed tomography (CT) and intravascular
hematoma).
Fig 4. Computed tomography (CT) and intravascular
eurysm).to the FDA approval of the first thoracic endograft (TAG,W.L. Gore) in the US. Although endovascular repair of
TAI using abdominal aortic components has been re-
ported, we have generally limited the endovascular ap-
proach at our institution to patients who met sizing criteria
for off-label use of thoracic devices.12-14 (We made one
sound (IVUS) images of a grade II injury (intramural
sound (IVUS) images of a grade III injury (pseudoan-




repair (ER) P value
Total number 15 27
Grade 2 2 3 1.0
Grade 3 13 24 .61
Age (years) 31.1 47.8  .006
Mean ISS 34.4 36.7 .42
Aortic diameter(mm) 19.6 24.4  .0001
Repair interval (days) 1.3 6.5 .10
Mortality 0 0 1.0
Stroke 0 1 (3.7%) 1.0
Paraplegia 0 0 1.0
ICU LOS (days) 21.9 15.7 .37
Hospital LOS (days) 33.7 27.3 .48
Follow-up (months) 27 15 .12ultraultraISS, Injury severity score; ICU, intensive care unit; LOS, length of stay.
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pseudoaneurysm who was not a candidate for open repair.
In this patient an Excluder [W.L. Gore] iliac limb was used
to repair a very small aorta.) The TAG device is available in
diameters of 26 to 40 mm to treat aortas between 23 to 37
mm. During the initial phase of our study, patients with
aortic diameters less than 23 mm were offered OR. This
affect likely accounts for the significant difference in the age
of patients and the size of the aortic diameter proximal to
the area of injury in the OR vs the TEVAR group. The OR
patients were significantly older with larger aortas com-
pared to the TEVAR group. With the approval of the
Talent thoracic device (Medtronic) in 2008, which ranges
in diameter from 22-46 mm, we were able to offer endo-
vascular repair to a wider range of patients. Overall, 64%
(27/42) of our study cohort met criteria for TEVAR with
the off-label use of an approved thoracic device. One pa-
tient who met sizing criteria for TEVAR underwent OR
due to severe aortoiliac occlusive disease extending to the
renal arteries. Future generations of devices tailored to
repair of traumatic injury will undoubtedly expand the
applicability of this technology to a wider range of patients.
A number of recent meta-analyses have documented
significantly improved outcomes after TEVAR compared
to OR.5-7 A survival benefit for TEVAR patients was also
demonstrated in a prospective multicenter study conducted
by the American Association for the Surgery of Trauma
(AAST).15 Our study, however, did not show a significant
difference in outcomes. This can likely be attributed to a
small sample size and the protective use of distal aortic
perfusion in the OR group. There was no mortality or
paraplegia among the patients who underwent open or
endovascular repair. There was one posterior stroke in an
80-year-old woman who underwent TEVAR. In retro-
spect, this event can be attributed to the severity of the
disease in the aortic arch. It is difficult to perform any
meaningful statistical analysis with only a single patient
reaching an endpoint. Our study demonstrates that the
results of TEVAR do not differ from OR. These findings
support the use of TEVAR as a first line treatment for TAI.
Management of the left subclavian artery (LSCA) dur-
ing TEVAR remains a topic of interest. The mechanism of
injury often places the tear very close to the distal arch.16 In
our experience, nearly half of the patients (48%) required
LSCA coverage in order to obtain an adequate proximal
landing zone or arch apposition. We maintained a policy of
delayed LSCA transposition or bypass as clinically indi-
cated. We performed a diagnostic arch angiogram prior to
TEVAR in order to define the cerebrovascular anatomy.
We did not encounter any patients with inadequate collat-
eral vertebral flow. One patient with a documented con-
comitant left brachial plexus injury underwent a delayed
LSCA bypass. This procedure was performed to rule out
any arterial ischemia as the cause of the neurologic symp-
toms. No other patient developed any left arm claudication
or ischemic symptoms during the follow-up period. Over-
all, a policy of delayed selective LSCA revascularization has
thus been successful in our experience.The AAST classifies all TAIs, regardless of severity, as a
grade 4 vascular injury.17 TAIs, however, include a spec-
trum of defects that range from small intimal tears to
complete transections with free rupture. Advances in imag-
ing, including refinements in CT scans and the use of
IVUS, have led to the diagnosis of injuries that may have
gone unrecognized in the past.18-21 The availability of a
more detailed classification system facilitates the study of
treatment strategies as well as outcomes. This is especially
relevant in the case of intimal tears (grade 1) which may
potentially be managed non-operatively.22 We certainly
recognize the inherent limits of this classification system.
First, this is a relatively small group of patients gathered
over a short period of time. As a result, meaningful out-
come data based on this classification system cannot be
provided yet. This will, however, be the subject of future
studies as we continue to follow our patients. The second
limitation relates to grade 4 injuries. We recognize that the
majority of these patients either die in the field or are too
unstable on arrival to undergo diagnostic studies. Autopsy
studies may at times be the only available information on
these patients.
CONCLUSION
Endovascular repair of TAI appears to be a suitable
alternative to OR as a first line therapy with favorable
results. Long-term follow-up is required to determine
the effectiveness of this treatment strategy. Adherence to
follow-up imaging protocols is challenging in this patient
population. The availability of next generation devices will
make endovascular repair applicable to a wider range of
patients. The use of a uniform classification system may be
helpful in assessment of outcomes, especially in patients
with minor injuries.
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